Peptide user tore oesophagus after using counterfeit product, Australian regulator warns
OMEGAZEPRIME News
This story was selected and curated by our editorial team in the Australia news category. Published on September 13, 2026 • Originally reported by Melissa Davey Medical editor. OMEGAZEPRIME provides independent news coverage and analysis for our readers. Stay informed with the latest developments.
This story was selected and curated by our editorial team in the Australia news category. Published on September 13, 2026 • Originally reported by Melissa Davey Medical editor. OMEGAZEPRIME provides independent news coverage and analysis for our readers. Stay informed with the latest developments.
TGA issues alert after person was hospitalised after believing they were taking experimental weight loss drug retatrutide
Get our breaking news email, free app or daily news podcast
A patient who tore their oesophagus after taking a counterfeit version of an experimental weight loss drug has prompted Australia’s medicines regulator to warn of serious risks of such products.
The concern relates to retatrutide, a type of drug known as a peptide. Retatrutide has not been approved by the Therapeutic Goods Administration (TGA) or regulators overseas, and it cannot be legally prescribed or sold in Australia.
Continue reading...OMEGAZEPRIME News — For more stories and analysis, visit omegazeprime.com